SCHEMBL21628688

SCHEMBL21628688

CN(C)C(=O)c1ccc(Oc2ccc(C3CCC3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
HPGD P15428 2/20 0.67
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
STAT3 P40763 4/20 0.47
MMP13 P45452 1/20 0.46
MAPT P10636 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
USP30 Q70CQ3 1/20 0.43
PARP10 Q53GL7 1/20 0.42
GPR119 Q8TDV5 3/20 0.42
RAB9A P51151 1/20 0.41
HSD11B1 P28845 1/20 0.40
CCR5 P51681 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628904 0.97 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL21628738 0.95 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL21628651 0.95 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL21628489 0.94 HPGD (0.71) ALDH1A1SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL21628652 0.84 HRH3 (0.48) ALDH1A1SMN1; SMN2HPGD
SCHEMBL21628380 0.83 SLC6A2 (0.46) ALDH1A1SMN1; SMN2HPGDPARP10GPR119
SCHEMBL21656804 0.81 PARP10 (0.53) ALDH1A1SMN1; SMN2MEN1KMT2ASTAT3
SCHEMBL21656805 0.80 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2HPGDMAPTHDAC1
SCHEMBL21628902 0.80 PARP10 (0.63) ALDH1A1KMT2APARP10
SCHEMBL21628888 0.79 SMN1; SMN2 (0.67) ALDH1A1SMN1; SMN2HPGDMMP13MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK ALDH1A1 900/4885SMN1; SMN2 1107/4885HPGD 2313/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR ALDH1A1 929/4885SMN1; SMN2 919/4885HPGD 3694/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.